The aim of this webinar is to provide updates on how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it helps make the management of a complex disease more simple. Furthermore, it will discuss how real-world evidence strengthens the safety and efficacy outcomes that were seen in the clinical trials.
Estimated time of Completion: 47 mins
CPD Points: 0.75 Point
PRC Program No: PROG-2022-47773
PC-PH-105025 / June 2023